High-performance capillary electrophoretic method for the quantification of 5-methyl 2'-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 12179987)

Published in Electrophoresis on June 01, 2002

Authors

Mario F Fraga1, Esther Uriol, L Borja Diego, María Berdasco, Manel Esteller, María Jesús Cañal, Roberto Rodríguez

Author Affiliations

1: Laboratorio de Fisiología Vegetal, Dpt. B.O.S., Facultad de Biología, Universidad de Oviedo, Oviedo, Spain. mffraga@CNIO.es

Articles citing this

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60

Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology (2008) 2.91

Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One (2012) 1.43

Capillary electrophoretic analysis of genomic DNA methylation levels. Nucleic Acids Res (2003) 1.19

DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta. J Biol Chem (2010) 1.15

Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS One (2013) 1.14

Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia (2007) 1.12

Promoter DNA hypermethylation and gene repression in undifferentiated Arabidopsis cells. PLoS One (2008) 1.09

Nucleosomes protect DNA from DNA methylation in vivo and in vitro. Nucleic Acids Res (2011) 1.08

Perspectives on deciphering mechanisms underlying plant heat stress response and thermotolerance. Front Plant Sci (2013) 1.02

Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide. Hepatology (2010) 0.99

A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer (2008) 0.95

Assessment of genetic and epigenetic stability in long-term in vitro shoot culture of pea (Pisum sativum L.). Plant Cell Rep (2007) 0.92

Sulfur-based redox alterations in long-lived Snell dwarf mice. Mech Ageing Dev (2013) 0.92

Dynamics of DNA methylation and Histone H4 acetylation during floral bud differentiation in azalea. BMC Plant Biol (2010) 0.90

DNA methylation dynamics and MET1a-like gene expression changes during stress-induced pollen reprogramming to embryogenesis. J Exp Bot (2012) 0.89

Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. World J Surg Oncol (2012) 0.84

DNA methylation during sexual embryogenesis and implications on the induction of somatic embryogenesis in Castanea sativa Miller. Sex Plant Reprod (2010) 0.84

A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation. BMC Res Notes (2011) 0.84

Modeling and Global Optimization of DNA separation. Comput Chem Eng (2014) 0.81

Dynamics and Reversibility of the DNA Methylation Landscape of Grapevine Plants (Vitis vinifera) Stressed by In Vitro Cultivation and Thermotherapy. PLoS One (2015) 0.81

FASTmC: A Suite of Predictive Models for Nonreference-Based Estimations of DNA Methylation. G3 (Bethesda) (2015) 0.77

Possible involvement of locus-specific methylation on expression regulation of leafy homologous gene (CiLFY) during precocious trifoliate orange phase change process. PLoS One (2014) 0.76

What's in a name? Context-dependent significance of 'global' methylation measures in human health and disease. Clin Epigenetics (2017) 0.75

Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study. Br J Cancer (2016) 0.75

DNA methylation as a potential diagnosis indicator for rapid discrimination of rare cancer cells and normal cells. Sci Rep (2015) 0.75

Use of Combined MSAP and NGS Techniques to Identify Differentially Methylated Regions in Somaclones: A Case Study of Two Stable Somatic Wheat Mutants. PLoS One (2016) 0.75

Articles by these authors

(truncated to the top 100)

Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46

The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet (2005) 8.45

Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics (2011) 7.38

Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29

A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A (2008) 7.14

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 7.09

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci (2003) 6.24

Cancer epigenetics reaches mainstream oncology. Nat Med (2011) 5.83

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62

DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol (2006) 4.38

A role for RNAi in the selective correction of DNA methylation defects. Science (2009) 4.30

Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A (2012) 4.26

Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol (2004) 4.15

Retracted A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet (2009) 3.88

Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res (2009) 3.81

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60

DNA methylation and cancer. Adv Genet (2010) 3.50

Epigenetics and aging: the targets and the marks. Trends Genet (2007) 3.44

DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet (2012) 3.33

BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol (2012) 3.24

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol (2009) 3.05

Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology (2008) 2.91

Low-level microsatellite instability in most colorectal carcinomas. Cancer Res (2002) 2.87

Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell (2010) 2.86

A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell (2010) 2.78

A systematic profile of DNA methylation in human cancer cell lines. Cancer Res (2003) 2.75

DNA methylation: a profile of methods and applications. Biotechniques (2002) 2.74

The role of histone deacetylases (HDACs) in human cancer. Mol Oncol (2007) 2.72

Notch signaling is essential for ventricular chamber development. Dev Cell (2007) 2.53

GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol (2003) 2.42

The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res (2003) 2.41

Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J (2002) 2.40

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood (2002) 2.34

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet (2006) 2.33

Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol (2005) 2.27

Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J (2007) 2.21

Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J (2003) 2.21

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 2.21

A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics (2009) 2.21

BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors. J Clin Oncol (2010) 2.18

Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci (2007) 2.17

A DNA methylation fingerprint of 1628 human samples. Genome Res (2011) 2.16

Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res (2006) 2.15

CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle (2007) 2.12

Cancer epigenomics: beyond genomics. Curr Opin Genet Dev (2012) 2.11

Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst (2004) 2.08

Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res (2003) 2.03

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97

Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet (2003) 1.93

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res (2004) 1.92

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res (2009) 1.87

DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem (2004) 1.82

Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. Biotechniques (2008) 1.81

Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett (2010) 1.79

Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet (2003) 1.77

E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J (2005) 1.76

Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol (2012) 1.73

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer (2004) 1.72

Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res (2007) 1.71

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A (2006) 1.70

Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res (2004) 1.66

DNA methylation contributes to natural human variation. Genome Res (2013) 1.66

Epigenetic disruption of the PIWI pathway in human spermatogenic disorders. PLoS One (2012) 1.64

Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment. Genome Res (2014) 1.64

Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem (2004) 1.64

Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet (2004) 1.60

Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia (2010) 1.58

Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol (2008) 1.57

Histone deacetylase inhibitors: understanding a new wave of anticancer agents. Int J Cancer (2004) 1.57

Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat Struct Mol Biol (2012) 1.56

The epigenetic face of systemic lupus erythematosus. J Immunol (2006) 1.55

MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol (2010) 1.49

Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A (2010) 1.48

A prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol (2013) 1.47

CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia. J Exp Med (2009) 1.47

Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene (2002) 1.46

Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One (2008) 1.45

A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res (2004) 1.44

Aberrant regulation of messenger RNA 3'-untranslated region in human cancer. Cell Oncol (2007) 1.44

Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle (2005) 1.44

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer (2002) 1.44

Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer (2003) 1.43

Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells. Nucleic Acids Res (2007) 1.42

How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle (2009) 1.41

DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol (2008) 1.40

Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. Cancer Res (2003) 1.39

Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One (2012) 1.38

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin Cancer Res (2005) 1.38

Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res (2002) 1.37

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res (2005) 1.37

MGMT hypermethylation: a prognostic foe, a predictive friend. DNA Repair (Amst) (2007) 1.33

The epigenetic basis of twin discordance in age-related diseases. Pediatr Res (2007) 1.32

Cancer epigenetics and methylation. Science (2002) 1.31

A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res (2006) 1.29

Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J Clin Oncol (2005) 1.28

The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis (2007) 1.27

Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc Natl Acad Sci U S A (2009) 1.27

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Genes Chromosomes Cancer (2004) 1.27

Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics (2010) 1.26